Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
17 June 1999Website:
http://www.unither.comNext earnings report:
21 February 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | 7 min agoDividend
Analysts recommendations
Institutional Ownership
UTHR Latest News
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
UTHR reports better-than-expected results in third-quarter 2024 on the back of strong demand for its treprostinil medications, especially Tyvaso.
United Therapeutics Corporation (NASDAQ:UTHR ) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants Dewey Steadman - Head of Investor Relations Martine Rothblatt - Chairperson & Chief Executive Officer Michael Benkowitz - President & Chief Operating Officer James Edgemond - Chief Financial Officer & Treasurer Leigh Peterson - Executive Vice President-Product Development & Xenotransplantation Conference Call Participants Joseph Thome - TD Cowen Roanna Ruiz - Leerink Partners Andreas Argyrides - Oppenheimer Roger Song - Jefferies Jessica Fye - JPMorgan Ash Verma - UBS Operator Good morning, and welcome to the United Therapeutics Corporation Third Quarter 2024 Earnings Webcast. My name is Dave, and I will be your conference operator today.
Although the revenue and EPS for United Therapeutics (UTHR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Beyond analysts' top -and-bottom-line estimates for United Therapeutics (UTHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its third quarter 2024 financial results before the market opens on Wednesday, October 30, 2024. A press release detailing the quarterly results will be issued that day at approximately 6:30 a.m. Eastern Time. United Therapeutics will host a public webcast Wednesday, October 30, 2024, at 9:00 a.m. Eastern Time. The webcast will be accessible via.
Revenue growth and a recent regulatory win are driving shares of United Therapeutics Corporation (UTHR) upward.
Does United Therapeutics (UTHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
What type of business is United Therapeutics?
United Therapeutics Corporation is an American biotechnology company that develops and markets pharmaceuticals for patients with severe chronic diseases. Currently, the company's product portfolio includes four commercial drugs for the treatment of pulmonary arterial hypertension (PAH): Remodulin (treprostinil) - a drug approved by the FDA for subcutaneous and intravenous administration in 2002 and 2004, respectively; Tyvaso (treprostinil) - a drug approved by the FDA in 2009; Orenitram (treprostinil) - the only FDA-approved orally administered analog of prostacyclin; Adcirca (tadalafil) - a PDE-5 inhibitor, with tadalafil as the active pharmaceutical ingredient. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland.
What sector is United Therapeutics in?
United Therapeutics is in the Healthcare sector
What industry is United Therapeutics in?
United Therapeutics is in the Biotechnology industry
What country is United Therapeutics from?
United Therapeutics is headquartered in United States
When did United Therapeutics go public?
United Therapeutics initial public offering (IPO) was on 17 June 1999
What is United Therapeutics website?
https://www.unither.com
Is United Therapeutics in the S&P 500?
No, United Therapeutics is not included in the S&P 500 index
Is United Therapeutics in the NASDAQ 100?
No, United Therapeutics is not included in the NASDAQ 100 index
Is United Therapeutics in the Dow Jones?
No, United Therapeutics is not included in the Dow Jones index
When was United Therapeutics the previous earnings report?
No data
When does United Therapeutics earnings report?
The next expected earnings date for United Therapeutics is 21 February 2025